The proposed underlying mechanisms of fibrosis in EM include transforming growth factor-alpha (TGF-α) and eosinophil-derived neurotoxin-induced fibroblast proliferation, as well as extracellular matrix deposition mediated by transforming growth factor-beta (TGF-β) [25-27]. This evidence concerns the gene TGFB1 and erythema multiforme.